AOD 9604 Powder CAS 221231-10-3

Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of aod 9604 powder cas 221231-10-3 in China. Welcome to wholesale bulk high quality aod 9604 powder cas 221231-10-3 for sale here from our factory. Good service and reasonable price are available.

AOD 9604 powder is a synthetic peptide fragment with a molecular weight of 5138.77 g/mol, CAS registry number 221231-10-3, and molecular formula C₇₈H₁₂₃N₂₃O₂₃S₂. Its relatively compact molecular weight confers favorable tissue permeability and efficient systemic absorption in biological environments, supporting its potential for effective delivery and action within the body. The compound exhibits good solubility characteristics, readily dissolving in water and a range of common laboratory and pharmaceutical solvents, and is typically manufactured and supplied as a stable powder formulation, which is reconstituted in solution prior to experimental or clinical use. AOD 9604 demonstrates notable thermal stability, permitting storage and handling at moderately elevated temperatures within a defined operational range; however, prolonged exposure to extreme high temperatures may induce structural degradation and subsequent loss of biological activity. It also maintains stability across a broad pH spectrum, retaining functional integrity from acidic to alkaline conditions, and remains relatively resistant to degradation and deactivation in aqueous environments. This stability profile enhances its suitability for formulation into injections, solutions, or other dosage forms, supporting reliable preparation and administration. Under appropriate crystallization conditions, AOD 9604 can form well‑defined crystal structures, including single‑crystal and polycrystalline morphologies, a property that is valuable for structural characterization, analytical validation, and certain research methodologies. Biochemically, AOD 9604 is classified as a human growth hormone fragment, often described as a repair‑type or regenerative hGH fragment, consisting of 44 consecutive amino acid residues derived from the C‑terminal region of the native human growth hormone polypeptide chain.

AOD 9604 Powder COA

AOD 9604 powder is a synthetic peptide compound. The chemical name is L-Phenylalanine. L - tyrosyl - L - leucyl - L - arginyl - L - isoleucyl - L - valyl - L - glutaminyl - L - cysteinyl - L - arginyl - L - seryl - L - valyl - L - alpha glutamylglycyl - L -Seryl-L-Cysteinylglycyl -, cyclic (7→14)-disulfide, with the molecular formula C78H123N23O23S2 and a molecular weight of 1815.1. The following elaborates on its chemical properties from multiple aspects.

Storage and usage precautions

 

Storage conditions

For short-term storage (within one month), it can be kept at -20℃. For long-term storage, it should be stored at -80℃ in deep cold and avoid repeated freezing and thawing.

Solution preparation

It is recommended to dissolve in sterile water for injection or physiological saline. After preparation, it should be aliquoted and stored to avoid cross-contamination.

Safety precautions

Protective gloves and goggles must be worn during operation to avoid inhalation or skin contact. Waste should be treated harmlessly in accordance with the norms for the treatment of chemical reagents.

AOD 9604 Powder is a polypeptide substance with significant biological activity of stimulating axunge breakdown and combustion, showing unique advantages in the fields of weight loss and weight management. The following elaborates in detail from aspects such as the mechanism of action, experimental evidence, and comparison with conventional methods.

 

 

The Impact of Usage Method and Time on the Effect

AOD 9604 is usually in injection form and is best used on an empty stomach in the morning. When the stomach is empty in the morning, the body is in a relatively hungry state. At this time, using AOD 9604 can enable the drug to enter the bloodstream better and take effect immediately. During this period, the body's metabolism is relatively more active, and drugs can more effectively stimulate axunge breakdown and burning.

If it is chosen to be used at other times, such as after meals, the digestion and absorption of food may affect the absorption and utilization efficiency of the drug. Moreover, after meals, the blood sugar level of the body rises and insulin secretion increases. Insulin has the effect of inhibiting axunge breakdown, which may weaken the stimulating effect of AOD 9604 on axunge breakdown.

 

 

Synergistic Effects with Other substances

AOD 9604 can also have a synergistic effect with other substances in stimulating axunge breakdown and burning. For instance, when combined with exercise, exercise can increase the body's energy demand and promote the oxidative utilization of free fatty acids. The free fatty acids released by AOD 9604, which promotes axunge breakdown, can better meet the energy demands during exercise, thereby enhancing the effect of weight loss.

In addition, some natural weight loss ingredients, such as green tea extract and caffeine, also have a certain effect in promoting axunge metabolism. When used in combination with AOD 9604, they may produce a synergistic effect, further enhancing the effect of axunge breakdown and burning. However, it should be noted that when using these substances, scientific and reasonable principles should be followed to avoid adverse reactions caused by excessive use.

 

 

Safety and Potential Risks

Although AOD 9604 shows good effects in stimulating axunge breakdown and burning, it is currently mainly used for scientific research purposes and is not recommended for direct use on the human body. When conducting research with AOD 9604, it is necessary to strictly abide by the relevant safety regulations and operating procedures to ensure the safety of the laboratory personnel.

Because the mechanism of action of AOD 9604 is rather complex, it may have certain effects on the endocrine system of the body, etc. If it is blindly used on the human body without thorough research and verification, it may cause some potential risks, such as endocrine disorders and immune system abnormalities. Therefore, before applying it to the human body, a large number of clinical trials and safety evaluations need to be conducted.

AOD 9604 Powder is a peptide substance related to growth hormone (GH), which has shown potential application value in regulating axunge metabolism and other aspects. Growth hormone activates a series of signaling pathways by binding to the growth hormone receptor (GHR) on the surface of target cells, thereby regulating various physiological processes such as growth, development, and metabolism in the body. The GH receptor binding domain is a critical region for the interaction between GH and GHR, and the stability and specificity of its sequence and structure are crucial for normal physiological functions. Ice age is an extremely cold period in Earth's history, during which animals faced severe environmental challenges such as coldness and low food resources in their long-term evolution. In order to adapt to these special environments, animals during the ice age underwent significant adaptive changes in physiology, morphology, and behavior. The GH system, as an important system for regulating body growth and metabolism, is likely to have played a key role in the adaptive evolution of ice age animals. Therefore, studying the conserved sequence differences of GH receptor binding domains in ice age animals can help reveal the adaptation mechanisms of animals in extreme environments and also contribute to the development of GH based drugs.

 Research Materials
Select representative glacial and non glacial animals as research subjects. Ice age animals include extinct species such as mammoths, woolly rhinoceroses, and cave bears (whose related gene sequence information is obtained through ancient DNA technology), as well as existing animals adapted to cold environments such as polar bears and reindeer; Non glacial animals choose common species such as humans, mice, rats, cows, and sheep. Collect the amino acid or nucleotide sequences of the GH receptor binding domain of these animals.

Research Methods

Search and download the GH receptor binding domain sequence of the selected animal through public databases such as NCBI's GenBank database, Ensembl database, etc. For extinct glacial animals, refer to relevant ancient DNA research literature to obtain validated sequence data.

Use bioinformatics software such as BioEdit, DNAMAN, etc. to organize and edit the obtained sequences, remove low-quality sequences and redundant information, and ensure the accuracy and consistency of the sequences. For nucleotide sequences, translate them into amino acid sequences according to the codon table for subsequent conservative sequence alignment analysis.

Use various sequence alignment tools for conservative sequence alignment, including ClustalW, MAFFT, and T-Coffee. These tools use different algorithms and strategies to align sequences from different perspectives, improving the accuracy of alignment results. Import the comparison results into professional sequence analysis software (such as MEGA, Jalview, etc.) for visual display and further analysis.

Based on conservative sequence alignment results, analyze the differences in GH receptor binding domains between ice age animals and non ice age animals. Specifically, it includes the following aspects:

Differences in amino acid composition: Count the frequency of various amino acids in the binding domain of GH receptors in different species, and compare the differences in amino acid composition between ice age animals and non ice age animals.

Differential Analysis

Conservative site analysis: Determine the conserved and variable sites in the GH receptor binding domain, and analyze the amino acid changes in animals during the ice age at these sites. Conservative sites usually remain relatively stable during evolution and are crucial for maintaining the structure and function of proteins; And variable loci may reflect adaptive evolutionary differences between species.

Differential Analysis

Sequence structure prediction: Use bioinformatics methods such as SWISS-MODEL, I-TASSER, etc. to predict the three-dimensional structure of GH receptor binding domains and compare the structural differences between ice age animals and non ice age animals. Structural differences may lead to changes in the affinity and specificity of GH binding to GHR, thereby affecting the biological functions of growth hormone.

Conservative sequence alignment results

 

The GH receptor binding domain sequences of glacial and non glacial animals were aligned using tools such as ClustalW, MAFFT, and T-Coffee, and consistent alignment results were obtained. Overall, the binding domain of GH receptors has a certain degree of conservation among different species, but there are also significant differences.

In the comparison results, some highly conservative regions and relatively variable regions can be clearly observed. The highly conserved region may contain key amino acid residues that bind to GH, which are crucial for maintaining receptor ligand interactions; The variable region may reflect the adaptive changes of different species during the evolutionary process.

Differences in Amino Acid Composition

 

The statistical results show that there are certain differences in the amino acid composition of the GH receptor binding domain between ice age animals and non ice age animals. For example, in ice age animals, the content of certain hydrophobic amino acids (such as leucine, isoleucine, valine, etc.) is relatively high, while the content of hydrophilic amino acids (such as serine, threonine, asparagine, etc.) is relatively low.

The difference in amino acid composition may be related to the physiological needs of ice age animals to adapt to cold environments.The increase of hydrophobic amino acids may help enhance the stability and frost resistance of proteins, allowing GH receptors to maintain their normal structure and function in low-temperature environments.

Sequence Structure Prediction Results

 

 

The three-dimensional structure of the GH receptor binding domain was predicted using tools such as SWISS-MODEL and I-TASSER, and the results showed that there were some structural differences between ice age animals and non ice age animals. The binding domain structure of GH receptors in ice age animals may be more compact, with changes in the arrangement and length of secondary structures in certain regions, such as alpha helices and beta folds. These structural differences may affect the binding mode and affinity of GH and GHR. For example, a compact structure may make the binding of GH receptors to GH in ice age animals more stable, which is beneficial for more effective utilization of growth hormone to regulate metabolic processes in low food resource environments.

Conservative Site Analysis

Multiple conserved sites have been identified in the GH receptor binding domain, which are highly conserved across different species, indicating their important functional significance in the evolutionary process. However, during the ice age, animals exhibited unique amino acid substitutions at some conserved sites. For example, at a key conserved site, non glacial animals mostly use aspartic acid, while some glacial animals replace it with glutamic acid. Although this amino acid substitution has similar properties, it may have subtle effects on the binding of GH and GHR, thereby regulating the signal transduction pathway of growth hormone to adapt to the special environmental conditions of ice age.

Hot Tags: aod 9604 powder cas 221231-10-3, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, dermorphin peptide, dermorphin in humans, Cosmetic, DERMORPHIN, Melanotan ii powder